Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Barbara Thorand is active.

Publication


Featured researches published by Barbara Thorand.


Molecular Systems Biology | 2012

Novel biomarkers for pre-diabetes identified by metabolomics

Rui Wang-Sattler; Zhonghao Yu; Christian Herder; Ana C. Messias; Anna Floegel; Ying He; Katharina Heim; Monica Campillos; Christina Holzapfel; Barbara Thorand; Harald Grallert; Tao Xu; Erik Bader; Cornelia Huth; Kirstin Mittelstrass; Angela Döring; Christa Meisinger; Christian Gieger; Cornelia Prehn; Werner Roemisch-Margl; Maren Carstensen; Lu Xie; Hisami Yamanaka-Okumura; Guihong Xing; Uta Ceglarek; Joachim Thiery; Guido Giani; Heiko Lickert; Xu Lin; Yixue Li

Type 2 diabetes (T2D) can be prevented in pre‐diabetic individuals with impaired glucose tolerance (IGT). Here, we have used a metabolomics approach to identify candidate biomarkers of pre‐diabetes. We quantified 140 metabolites for 4297 fasting serum samples in the population‐based Cooperative Health Research in the Region of Augsburg (KORA) cohort. Our study revealed significant metabolic variation in pre‐diabetic individuals that are distinct from known diabetes risk indicators, such as glycosylated hemoglobin levels, fasting glucose and insulin. We identified three metabolites (glycine, lysophosphatidylcholine (LPC) (18:2) and acetylcarnitine) that had significantly altered levels in IGT individuals as compared to those with normal glucose tolerance, with P‐values ranging from 2.4 × 10−4 to 2.1 × 10−13. Lower levels of glycine and LPC were found to be predictors not only for IGT but also for T2D, and were independently confirmed in the European Prospective Investigation into Cancer and Nutrition (EPIC)‐Potsdam cohort. Using metabolite–protein network analysis, we identified seven T2D‐related genes that are associated with these three IGT‐specific metabolites by multiple interactions with four enzymes. The expression levels of these enzymes correlate with changes in the metabolite concentrations linked to diabetes. Our results may help developing novel strategies to prevent T2D.


European Heart Journal | 2015

Mendelian randomization of blood lipids for coronary heart disease.

Michael V. Holmes; Folkert W. Asselbergs; Tom Palmer; Fotios Drenos; Matthew B. Lanktree; Christopher P. Nelson; Caroline Dale; Sandosh Padmanabhan; Chris Finan; Daniel I. Swerdlow; Vinicius Tragante; Erik P A Van Iperen; Suthesh Sivapalaratnam; Sonia Shah; Clara C. Elbers; Tina Shah; Jorgen Engmann; Claudia Giambartolomei; Jon White; Delilah Zabaneh; Reecha Sofat; Stela McLachlan; Pieter A. Doevendans; Anthony J. Balmforth; Alistair S. Hall; Kari E. North; Berta Almoguera; Ron C. Hoogeveen; Mary Cushman; Myriam Fornage

Aims To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. Methods and results We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10−6); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75). Conclusion The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.


BMJ | 2014

Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States

Ben Schöttker; Rolf Jorde; Anne Peasey; Barbara Thorand; Eugene Jansen; Lisette C. P. G. M. de Groot; Martinette T. Streppel; Julian Gardiner; José Manuel Ordóñez-Mena; Laura Perna; Tom Wilsgaard; Wolfgang Rathmann; Edith J. M. Feskens; Ellen Kampman; Galatios Siganos; Inger Njølstad; Ellisiv B. Mathiesen; R Kubinova; Andrzej Pająk; Abdonas Tamosiunas; Maria Hughes; Frank Kee; Martin Bobak; Antonia Trichopoulou; Paolo Boffetta; Hermann Brenner

Objective To investigate the association between serum 25-hydroxyvitamin D concentrations (25(OH)D) and mortality in a large consortium of cohort studies paying particular attention to potential age, sex, season, and country differences. Design Meta-analysis of individual participant data of eight prospective cohort studies from Europe and the US. Setting General population. Participants 26 018 men and women aged 50-79 years Main outcome measures All-cause, cardiovascular, and cancer mortality. Results 25(OH)D concentrations varied strongly by season (higher in summer), country (higher in US and northern Europe) and sex (higher in men), but no consistent trend with age was observed. During follow-up, 6695 study participants died, among whom 2624 died of cardiovascular diseases and 2227 died of cancer. For each cohort and analysis, 25(OH)D quintiles were defined with cohort and subgroup specific cut-off values. Comparing bottom versus top quintiles resulted in a pooled risk ratio of 1.57 (95% CI 1.36 to 1.81) for all-cause mortality. Risk ratios for cardiovascular mortality were similar in magnitude to that for all-cause mortality in subjects both with and without a history of cardiovascular disease at baseline. With respect to cancer mortality, an association was only observed among subjects with a history of cancer (risk ratio, 1.70 (1.00 to 2.88)). Analyses using all quintiles suggest curvilinear, inverse, dose-response curves for the aforementioned relationships. No strong age, sex, season, or country specific differences were detected. Heterogeneity was low in most meta-analyses. Conclusions Despite levels of 25(OH)D strongly varying with country, sex, and season, the association between 25(OH)D level and all-cause and cause-specific mortality was remarkably consistent. Results from a long term randomised controlled trial addressing longevity are being awaited before vitamin D supplementation can be recommended in most individuals with low 25(OH)D levels.


Diabetes Care | 2007

Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers Results from the MONICA/KORA Augsburg case-cohort study, 1984–2002

Barbara Thorand; Jens Baumert; Hubert Kolb; Christa Meisinger; Lloyd E. Chambless; Wolfgang Koenig; Christian Herder

OBJECTIVE—Although sex differences have been reported for associations between obesity and inflammation, the question of whether there is an effect modification by sex in the association between inflammation and type 2 diabetes has not been investigated in detail. Therefore, the aim of this study was to compare associations of markers of inflammation with type 2 diabetes risk between men and women. RESEARCH DESIGN AND METHODS—Following a case-cohort design, cases of incident type 2 diabetes were identified from 7,936 subjects aged 35–74 years at baseline who participated in the population-based Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)/Cooperative Research in the Region of Augsburg (KORA) studies conducted between 1984 and 2002. Concentrations of C-reactive protein (CRP) and interleukin (IL)-6 were measured in 527 cases of incident type 2 diabetes (305 men and 222 women) and 1,698 noncases (889 men and 809 women). RESULTS—After adjustment for age and survey and lifestyle factors including smoking, alcohol intake, and physical activity, elevated concentrations of CRP showed a considerably stronger association with risk of type 2 diabetes in women (hazard ratio comparing tertile extremes 7.60 [95% CI 4.43–13.04]) than in men (1.84 [1.27–2.67]). The P value for the sex interaction was <0.001. Further adjustment for metabolic risk factors considerably attenuated these associations, and they became nonsignificant in men but remained significant in women. IL-6 was also more strongly associated with type 2 diabetes in women, but there was no significant sex interaction. CONCLUSIONS—Our data suggest that inflammatory processes may be of particular importance in the pathogenesis of type 2 diabetes in women.


Arteriosclerosis, Thrombosis, and Vascular Biology | 2006

Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Wolfgang Koenig; Natalie Khuseyinova; Jens Baumert; Barbara Thorand; Hannelore Loewel; Lloyd E. Chambless; Christa Meisinger; Andrea L.C. Schneider; Stephan Martin; Hubert Kolb; Christian Herder

Objectives—We performed a prospective case–cohort study in initially healthy, middle-aged men and women from the MONICA/KORA Augsburg studies conducted between 1984 and 2002 to assess the role of IL-18 in comparison with IL-6 and CRP in the prediction of incident coronary heart disease (CHD). Methods and Results—Concentrations of IL-18 were measured in 382 case subjects with incident CHD and 1980 noncases. Mean follow-up was 11 years. Baseline concentrations of IL-18 were slightly higher in cases than in noncases (172.4 [1.0] versus 161.3 [1.0] pg/mL, respectively; P=0.114), but were clearly elevated for C-reactive protein (CRP) and IL-6 in cases compared with noncases. In multivariable analyses, accounting for classical cardiovascular risk factors and inflammatory markers, no statistically significant association was seen between increased concentrations of IL-18 and incident CHD both in men (hazard ratio [HR] and 95% confidence intervals [CIs] comparing extreme tertiles, 1.20; 95% CI, 0.85 to 1.69), and in women (HR, 1.25; 95% CI, 0.67 to 2.34). However, in this population increased concentrations of CRP and IL-6 were found to be independent predictors of future CHD events, even after multivariable adjustment. Conclusions—Elevated concentrations of CRP and IL-6, but not IL-18, were independently associated with risk of CHD in subjects from an area with moderate absolute risk.


Atherosclerosis | 2010

Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: Results of genome-wide association analyses including 4659 European individuals

Iris M. Heid; Peter Henneman; Andrew A. Hicks; Stefan Coassin; Thomas W. Winkler; Yurii S. Aulchenko; Christian Fuchsberger; Kijoung Song; Marie-France Hivert; Dawn M. Waterworth; Nicholas J. Timpson; J. Brent Richards; John Perry; Toshiko Tanaka; Najaf Amin; Barbara Kollerits; Irene Pichler; Ben A. Oostra; Barbara Thorand; Rune R. Frants; Thomas Illig; Josée Dupuis; Beate Glaser; Tim D. Spector; Jack M. Guralnik; Josephine M. Egan; Jose C. Florez; David Evans; Nicole Soranzo; Stefania Bandinelli

OBJECTIVE Plasma adiponectin is strongly associated with various components of metabolic syndrome, type 2 diabetes and cardiovascular outcomes. Concentrations are highly heritable and differ between men and women. We therefore aimed to investigate the genetics of plasma adiponectin in men and women. METHODS We combined genome-wide association scans of three population-based studies including 4659 persons. For the replication stage in 13795 subjects, we selected the 20 top signals of the combined analysis, as well as the 10 top signals with p-values less than 1.0 x 10(-4) for each the men- and the women-specific analyses. We further selected 73 SNPs that were consistently associated with metabolic syndrome parameters in previous genome-wide association studies to check for their association with plasma adiponectin. RESULTS The ADIPOQ locus showed genome-wide significant p-values in the combined (p=4.3 x 10(-24)) as well as in both women- and men-specific analyses (p=8.7 x 10(-17) and p=2.5 x 10(-11), respectively). None of the other 39 top signal SNPs showed evidence for association in the replication analysis. None of 73 SNPs from metabolic syndrome loci exhibited association with plasma adiponectin (p>0.01). CONCLUSIONS We demonstrated the ADIPOQ gene as the only major gene for plasma adiponectin, which explains 6.7% of the phenotypic variance. We further found that neither this gene nor any of the metabolic syndrome loci explained the sex differences observed for plasma adiponectin. Larger studies are needed to identify more moderate genetic determinants of plasma adiponectin.


Diabetic Medicine | 2009

Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study

Wolfgang Rathmann; Klaus Strassburger; Margit Heier; Rolf Holle; Barbara Thorand; Guido Giani; C. Meisinger

Aims  To determine the incidence of Type 2 diabetes in an elderly population in Germany and its association with clinical and lifestyle factors.


PLOS Medicine | 2012

Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias

Robert Clarke; Derrick Bennett; Sarah Parish; Petra Verhoef; Mariska Dötsch-Klerk; Mark Lathrop; Peng Xu; Børge G. Nordestgaard; Hilma Holm; Jemma C. Hopewell; Danish Saleheen; Toshihiro Tanaka; Sonia S. Anand; John Campbell Chambers; Marcus E. Kleber; Willem H. Ouwehand; Yoshiji Yamada; Clara C. Elbers; Bas Jm Peters; Alexandre F.R. Stewart; Muredach M. Reilly; Barbara Thorand; Salim Yusuf; James C. Engert; Themistocles L. Assimes; Js Kooner; John Danesh; Hugh Watkins; Nilesh J. Samani; Rory Collins

Robert Clarke and colleagues conduct a meta-analysis of unpublished datasets to examine the causal relationship between elevation of homocysteine levels in the blood and the risk of coronary heart disease. Their data suggest that an increase in homocysteine levels is not likely to result in an increase in risk of coronary heart disease.


The Lancet Diabetes & Endocrinology | 2015

Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study.

John Chambers; Marie Loh; Benjamin Lehne; Alexander Drong; Jennifer Kriebel; Valeria Motta; Simone Wahl; Hannah R Elliott; Federica Rota; William R. Scott; Weihua Zhang; Sian-Tsung Tan; Gianluca Campanella; Marc Chadeau-Hyam; Loic Yengo; Rebecca C Richmond; Martyna Adamowicz-Brice; Uzma Afzal; Kiymet Bozaoglu; Zuan Yu Mok; Hong Kiat Ng; François Pattou; Holger Prokisch; Michelle Ann Rozario; Letizia Tarantini; James Abbott; Mika Ala-Korpela; Benedetta Albetti; Ole Ammerpohl; Pier Alberto Bertazzi

BACKGROUND Indian Asians, who make up a quarter of the worlds population, are at high risk of developing type 2 diabetes. We investigated whether DNA methylation is associated with future type 2 diabetes incidence in Indian Asians and whether differences in methylation patterns between Indian Asians and Europeans are associated with, and could be used to predict, differences in the magnitude of risk of developing type 2 diabetes. METHODS We did a nested case-control study of DNA methylation in Indian Asians and Europeans with incident type 2 diabetes who were identified from the 8-year follow-up of 25 372 participants in the London Life Sciences Prospective Population (LOLIPOP) study. Patients were recruited between May 1, 2002, and Sept 12, 2008. We did epigenome-wide association analysis using samples from Indian Asians with incident type 2 diabetes and age-matched and sex-matched Indian Asian controls, followed by replication testing of top-ranking signals in Europeans. For both discovery and replication, DNA methylation was measured in the baseline blood sample, which was collected before the onset of type 2 diabetes. Epigenome-wide significance was set at p<1 × 10(-7). We compared methylation levels between Indian Asian and European controls without type 2 diabetes at baseline to estimate the potential contribution of DNA methylation to increased risk of future type 2 diabetes incidence among Indian Asians. FINDINGS 1608 (11·9%) of 13 535 Indian Asians and 306 (4·3%) of 7066 Europeans developed type 2 diabetes over a mean of 8·5 years (SD 1·8) of follow-up. The age-adjusted and sex-adjusted incidence of type 2 diabetes was 3·1 times (95% CI 2·8-3·6; p<0·0001) higher among Indian Asians than among Europeans, and remained 2·5 times (2·1-2·9; p<0·0001) higher after adjustment for adiposity, physical activity, family history of type 2 diabetes, and baseline glycaemic measures. The mean absolute difference in methylation level between type 2 diabetes cases and controls ranged from 0·5% (SD 0·1) to 1·1% (0·2). Methylation markers at five loci were associated with future type 2 diabetes incidence; the relative risk per 1% increase in methylation was 1·09 (95% CI 1·07-1·11; p=1·3 × 10(-17)) for ABCG1, 0·94 (0·92-0·95; p=4·2 × 10(-11)) for PHOSPHO1, 0·94 (0·92-0·96; p=1·4 × 10(-9)) for SOCS3, 1·07 (1·04-1·09; p=2·1 × 10(-10)) for SREBF1, and 0·92 (0·90-0·94; p=1·2 × 10(-17)) for TXNIP. A methylation score combining results for the five loci was associated with future type 2 diabetes incidence (relative risk quartile 4 vs quartile 1 3·51, 95% CI 2·79-4·42; p=1·3 × 10(-26)), and was independent of established risk factors. Methylation score was higher among Indian Asians than Europeans (p=1 × 10(-34)). INTERPRETATION DNA methylation might provide new insights into the pathways underlying type 2 diabetes and offer new opportunities for risk stratification and prevention of type 2 diabetes among Indian Asians. FUNDING The European Union, the UK National Institute for Health Research, the Wellcome Trust, the UK Medical Research Council, Action on Hearing Loss, the UK Biotechnology and Biological Sciences Research Council, the Oak Foundation, the Economic and Social Research Council, Helmholtz Zentrum Munchen, the German Research Center for Environmental Health, the German Federal Ministry of Education and Research, the German Center for Diabetes Research, the Munich Center for Health Sciences, the Ministry of Science and Research of the State of North Rhine-Westphalia, and the German Federal Ministry of Health.


Arteriosclerosis, Thrombosis, and Vascular Biology | 2005

Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population

Barbara Thorand; Jens Baumert; Lloyd E. Chambless; Christa Meisinger; Hubert Kolb; Angela Döring; Hannelore Löwel; Wolfgang Koenig

Objective—Using the Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)/Cooperative Research in the Region of Augsburg (KORA) database, we investigated prospectively whether increased levels of soluble E-selectin (sE-selectin), soluble intercellular adhesion molecule 1 (sICAM-1), and von Willebrand factor (vWF), all considered to be sensitive markers of endothelial dysfunction, are associated with an increased risk of incident type 2 diabetes mellitus. Methods and Results—In a case–cohort study, concentrations of adhesion molecules were measured in stored samples of 532 case subjects and 1712 noncase subjects. VWF was measured in a subsample with available plasma samples (n=191 case and 580 noncase subjects). Men and women with elevated levels of sE-selectin had a significantly increased risk of type 2 diabetes after multivariable adjustment. Hazard ratios (95% CIs) comparing tertile extremes of sE-selectin were 2.63 (1.79 to 3.88) and 1.71 (1.07 to 2.75) for men and women, respectively. Elevated levels of sICAM-1 were also associated with an increased risk of type 2 diabetes; however, the association was not independent of other diabetes risk factors including E-selectin [hazard ratio (95% CI) for tertile 3 versus tertile 1: men, 1.32 (0.89 to 1.96); women, 1.03 (0.64 to 1.67)]. In this study, vWF was not associated with risk of type 2 diabetes. Conclusions—These data support a role of endothelial dysfunction in the etiology of type 2 diabetes.

Collaboration


Dive into the Barbara Thorand's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rolf Holle

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar

Michael Roden

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar

Thomas Illig

Hannover Medical School

View shared research outputs
Top Co-Authors

Avatar

C. Meisinger

Wellcome Trust Sanger Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge